SANUWAVE Health, Inc.
NASDAQ:SNWVMedical - Devices
+$0.18 today
- Market cap
- $51.01M
- Beta
- 1.34
- P/E (TTM)
- 5.0
- EPS (TTM)
- $1.87
Volume 0.04M
Average 0.11M
SNWV Investing Cash Flow
Net cash used in or generated by investments in assets, acquisitions, and securities.
SANUWAVE Health, Inc.NASDAQ: SNWV
Investing Cash Flow · Q1 FY2026 · quarter ended Mar 2026
Investing cash flow dips below year-ago levels
Q1 FY2026 investing cash flow of $158K (cash outflow) fell 2.5% year over year, behind the +738.8% change in trailing-twelve-month investing cash flow. Over 3 fiscal years it compounded at +117.9% a year.
Context
- Investing cash flow amounted to 7.8% of revenue in FY2025, up 6.3 pp from a year earlier.
- Investing cash flow increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -2.5% toward the trailing-twelve-month pace of +738.8%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Investing Cash Flow history
USD · from the cash flow
- Latest · FY2025
- 3.43M USD
- Year-over-year change
- +800.6%
| Period | Period end | Investing Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 3.43M | +800.6% |
| FY2024 | 2024-12-31 | (490K) | -2433.3% |
| FY2023 | 2023-12-31 | 21K | -93.7% |
| FY2022 | 2022-12-31 | 332K | +162.8% |
| FY2021 | 2021-12-31 | (529K) | — |
Investing Cash Flow vs competitors
How SNWV compares with its peers on the latest reported figures
- SNWV's LTM Mar 2026 investing cash flow of $3.44M is the 9th largest of the 11 companies compared; the peer median is $5.83M.
- Its year-over-year change of +738.8% is the 2nd highest of 10, against a peer median of -28.4%.
- Investing cash flow amounts to 7.8% of revenue for SNWV, versus a peer median of 24.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $421.06M | — | +3284.7% | 4391.1% | |
| LTM Mar 2026 | $151.8M | -3115.8% | — | — | |
| LTM Mar 2026 | $64.92M | +335.2% | — | 230.0% | |
| LTM Mar 2026 | $42.73M | -28.4% | — | 29.5% | |
| LTM Dec 2025 | $31.01M | +254.6% | +26.2% | 238.1% | |
| LTM Mar 2026 | $26.15M | +917.8% | +34.1% | 7.4% | |
| LTM Mar 2026 | $11.71M | -113.8% | +13.8% | 10.0% | |
| LTM Mar 2026 | $10.1M | -43.5% | — | 24.8% | |
| LTM Mar 2026 | $3.44M | +738.8% | +117.9% | 7.8% | |
| LTM Mar 2026 | $1.56M | -115.9% | — | 2.7% | |
| LTM Mar 2026 | $284K | +6.0% | -38.6% | 0.4% | |
| Peer median (excluding SNWV) | $5.83M | -28.4% | +26.2% | 24.8% | |
Competitors are the stored peer set for SNWV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (27.26M) | (10.29M) | (25.81M) | (31.37M) | 11.81M |
| Depreciation & Amortization | 1.24M | 952K | 1.03M | 1.15M | 1.28M |
| Deferred Income Tax | 28K | 2K | 4K | 0 | 0 |
| Stock-Based Compensation | 0 | 0 | 0 | 1.51M | 0 |
| Change in Working Capital | 9.93M | (1.12M) | (3.61M) | (2.9M) | (4.01M) |
| Accounts Receivables | (395K) | (1.75M) | (53K) | (486K) | (2.3M) |
| Inventory | 1.69M | (72K) | (2.8M) | (1.2M) | (2.28M) |
| Accounts Payables | 3.18M | (2.55M) | 1.55M | (1.42M) | (521K) |
| Other Working Capital | 5.46M | 3.25M | (2.3M) | 203K | 1.09M |
| Other Non-Cash Items | 9.66M | (6.71M) | 23.84M | 34.07M | (5.21M) |
| Operating Cash Flow | (6.41M) | (17.17M) | (4.54M) | 2.46M | 3.88M |
| Capital Expenditures | (529K) | 1.02M | 0 | (490K) | (1.94M) |
| Acquisitions (Net) | 0 | 332K | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | (1.02M) | 21K | 0 | 5.38M |
| Investing Cash Flow | (529K) | 332K | 21K | (490K) | 3.43M |
| Debt Repayment | 3.38M | 16.59M | 5.85M | (2.46M) | (6.14M) |
| Common Stock Issued | 0 | 100K | 0 | 10.3M | 556K |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 1.74M | 695K | (639K) | (1.49M) | 0 |
| Financing Cash Flow | 5.12M | 17.38M | 5.21M | 6.35M | (5.59M) |
| Effect of Forex Changes | (1K) | (13K) | (50K) | 121K | 0 |
| Net Change in Cash | (1.82M) | 534K | 644K | 8.44M | 1.72M |
| Free Cash Flow | (6.94M) | (16.15M) | (4.54M) | 1.97M | 1.93M |
SANUWAVE Health, Inc.
NASDAQ:SNWV
Intrinsic Alpha fair value
Locked
Current Price
$5.93
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.